EFFECTIVENESS OF IVERMECTIN IN THE PROPHYLAXIS OF COVID-2019 IN PATIENTS OF THE REGIONAL OF ICA APRIL 2021

Received: 17.09.2021; Revised: 26.10.2021, Accepted: 22.11.2021, Published Online: 16.12.2021

Leveau-Bartra Harry R

San Juan Bautista Private University. Subsidiary-Ica, Biostatistical Surgeon General, (ORCID: 0000-0001-9632-7793), kahaisail4@hotmail.com

Chávez-Navarro Juan R

Federico Villarreal National University, Bachelor of Psychology, (ORCID: 0000-0002-0187-6165)

Choque-Gutierrez L

San Juan Bautista Private University. Subsidiary-Ica, Internist, (ORCID: 0000-0001-9799-2488)

Leveau-Vásquez Harry I

San Juan Bautista Private University. Subsidiary-Ica., Surgeon, (ORCID: https://orcid.org/0000-0001-8093-0475)

Leveau Vásquez Isabella K

San Juan Bautista Private University. Subsidiary-Ica, Surgeon, (ORCID: https://orcid.org/0000-0003-2690-8861)

ABSTRACT

Introduction. For the new coronavirus Sars-Cov-2 it still does not have effective treatment, so it only remains to take protective measures.

Objective: To determine the effectiveness as a prophylactic of severe cases of COVID-19 of the consumption of ivermectin in hospitalized patients in the COVID areas of the Regional Hospital of Ica from March to April 2021.

Material and methods. An observational, cross-sectional, analytical retrospective study of case control design, with 253 cases that consumed ivermectin with 133 control patients who did not consume ivermectin.

Results: 65.5% of the study participants consumed ivermectin at least 48 hours before their admission to the hospital in doses of 200 ug / Kg per day. 52.6% of the patients attended in severe stages according to tomographic Score. There are no significant differences between the patients who consumed ivermectin and those who did not, regarding the stage of their disease at the time of their admission to the hospital, both as a severity index by Score categorized as numerical based on 25/25 according to the tomography. Of the patients treated for COVID-19, 65.5% ingested ivermectin, under the behavior of not presenting the disease. The patients who consumed ivermectin, 18.7% stated that they stopped using masks when they felt protected by said drug, a behavior that causes a greater probability of infection by Sars-Cov-2.

Conclusions: Ivermectin consumption is not effective as a prophylaxis to reduce the severity of COVID-19 pictures. 65.5% ingested ivermectin, and 18.7% stated that they stopped using masks when they felt protected by said drug.

Keywords: Effectiveness, ivermectin, COVID-19